Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect

The combination of MEK inhibitor (cobimetinib, trametinib) and BRAF inhibitor (vemurafenib, dabrafenib) is now the first-line treatment in patients with BRAF V600-mutated metastatic melanoma. This association reduces cutaneous adverse events induced by BRAF inhibitors alone, including photosensitivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Negulescu, Miruna, Deilhes, Florian, Sibaud, Vincent, Tournier, Emilie, Lamant, Laurence, Boulinguez, Serge, Meyer, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465775/
https://www.ncbi.nlm.nih.gov/pubmed/28611627
http://dx.doi.org/10.1159/000461571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465775/
https://www.ncbi.nlm.nih.gov/pubmed/28611627
http://dx.doi.org/10.1159/000461571

Ejemplares similares